Key Takeaways
- Strong quarter, regulatory overhang: Equity net sales hit a record, AUM grew 17% YoY, and the Indus acquisition closed, but a SEBI draft proposing 6-7 bps TER cuts and unresolved insurance GST changes cloud the revenue outlook.
- SIP engine keeps compounding: Monthly SIP book reached ₹1,085 crores, market share improved 10 bps to 3.5%, and management targets ₹1,200 crores by March 2026.
- Insurance revenue grew 11.5% sequentially on strong fresh premiums, but GST-driven commission restructuring on 70% of health and 30% of life premiums makes the final revenue picture uncertain until year-end.
- Profit growth muted by one-offs: Combined ₹4.3 crores hit from lower treasury income and an incremental trail commission provision masked what management calls broadly in-line operational profit growth.
- What to watch next quarter: The SEBI consultation outcome and its pass-through mechanics, final clarity on insurance GST revenue impact, and whether the H2 commission provisioning eases as guided.
AUM Growth & the SIP Flywheel
- Daily AUM momentum: H1 daily average AUM was ~₹1,14,600 crores; current AUM has risen to ~₹1,27,000 crores, an 11% jump that provides a strong base for H2 revenue. Quarterly average AUM grew 17% YoY and 8% QoQ.
- Equity AUM resilient: Equity AUM grew 13.2% YoY driven primarily by strong net sales, with negative mark-to-market impact contained to just 1.4% versus the Nifty 500 decline of 6.2%. Management credits rupee cost averaging and its fund selection role. QoQ equity AUM grew 3.3% on net sales of ₹3,600 crores plus ~₹2,050 crores from the Indus acquisition, making it one of the strongest net equity sales quarters in Prudent's history.
- SIP market share rising: Monthly SIP book stands at ₹1,085 crores, adding ~₹210 crores over 12 months. Market share improved 10 bps to 3.5%. The stated target is ~₹1,200 crores in monthly SIP flow by March 2026.
- Mid/small cap mix steady: Mid and small cap contribution is around 23-24% of equity assets, with new SIP registrations in these categories at about one-third, a proportion management says is historically consistent.
Regulatory & GST: The Revenue Overhang
- SEBI draft consultation paper: Proposes three changes with a combined TER impact of 6-7 bps: expense ratio exclusive of GST (revenue-neutral for GST-registered distributors but removes an anomaly), removal of the 5 bps exit load benefit with a 5 bps TER increase in the first two slabs (net industry impact ~4-4.5 bps reduction), and brokerage reduction on cash and derivatives transactions (2-2.5 bps impact). Feedback deadline is 17th November.
- Pass-through expectation: Management's reading from AMC discussions is that the majority of the TER cut will be passed on to distributors this time. If the impact reaches distributors, Prudent says it will also share the pain with its own distribution partners. Some relaxation on exit load or brokerage could dilute the overall impact.
- Insurance GST still unresolved: In health insurance, ~70% of premium got impacted as commission structures shifted from "20% plus GST" to "20% includes GST," an effective reduction. In life insurance, ~30% of business saw an 18% revenue cut due to GST transferred to Prudent, but no consistent trend has emerged. Final clarity on life insurance is expected only by the March quarter, with a few more insurers likely to give clarity this quarter.
- Pass-through confidence on insurance: Management is confident it can pass on the GST hit to its distribution community at least equal to the sharing ratio or a little higher in the insurance segment.
Sanjay Shah: "To be very honest, clarity is not fully emerging. A lot of discussions are happening with the insurance companies."
Shirish Patel: "My gut feeling or my discussion with them this time, they will be able to pass it on, they will pass it on majority of the cut to the distributor. That is what my reading is."
Revenue & Profitability Mechanics
- MF revenue tracking AUM: Quarterly average AUM grew 8% sequentially while MF revenue grew 9%, helped by stable yield and one additional day (~₹3 crores). On a half-yearly basis, AUM grew 19.8% versus revenue growth of 18.4%, a marginal gap attributed to back book repricing that started in August last year.
- Insurance yield dip explained: Sequential decline in insurance yields was due to a base effect: ~₹3.5 crore in revenue from an earlier period was recognized in Q1 FY26. Adjusting for this, yield remained stable.
- Non-financial products decline: Revenue fell YoY primarily due to the absence of liquiloan in the current fiscal, which earned ₹6.9 crores last year and ₹6.2 crores in H1. The base effect will taper off in H2, and management expects healthy YoY growth to resume.
- Commission expense elevated temporarily: Commission and fee expenses rose 10% versus 8.9% revenue growth due to an additional trail commission provision. H1 FY25 provisioning was lower by ₹4.1 crores, with the full ₹19.1 crores booked in H2. This year provisioning is more evenly phased: ₹3 crores in Q1, ₹5.2 crores in Q2. The incremental ₹2 crore provision temporarily pushed commission growth above revenue growth. Management expects lower provisioning in H2 versus last year.
- Treasury income drag: Operational profit grew 7.3% sequentially but overall profit growth was muted by lower treasury income from MTM losses on the equity portfolio and lower yields on bank term deposits, causing a partial reversal of earlier gains. Combined with the incremental trail provision, the total impact was ₹4.3 crores. Adjusting for this, management says profit growth was broadly in line with revenue growth.
Indus Acquisition & Capital Allocation
- Deal closed, cash-accretive: The Indus merger is complete and is described as highly cash-accretive. It brings 15 experienced relationship managers under a seasoned business head, with expected annualized MF commission of ~₹22-23 crores and cash PBT of ~₹15 crores.
- Inorganic appetite intact: A treasury corpus of ₹480 crores provides the ability to pursue select inorganic opportunities that are strategically relevant and value-creative.
- ESOP grant: 1,30,945 options were granted to 388 employees at an option value of ~₹542 per share. The P&L hit of ~₹7.10 crores will be amortized equally over 12 months under share-based payment expenditure.
- Indus amortization open: Management has yet to discuss with its auditor whether to continue with the existing 10-year amortization formula or make changes, viewing the acquisition as a long-term asset.
Distribution Strength & Competitive Positioning
- Distributor recruitment accelerating: Last full year recruited 4,800+ new MFDs/ARN holders, one of the highest in history. The current fiscal YTD has already added close to 3,100, proportionately ahead of last year. Despite increased competition, management sees no impact on recruitment.
- Commission sharing strategy unchanged: Weighted average sharing in the indirect channel is 67%-68%. Competitors have offered higher commercial sharing for over 1.5 years, but Prudent has not changed its pass-out strategy and reports no impact on pass-outs. Management intends to maintain the same sharing ratio.
- Top partner retention near-absolute: Management states there is "zero attrition among top 10% partners or top 20% of our partners," though it did not provide the requested trend data across prior years.
- Insurance migration complete: Over the last year, the insurance business was migrated from Gennext to Prudent, with the majority of business starting in Prudent from 1st April. This transition caused some challenges in POSP recruitment.
Shirish Patel: "Last 1.5 years, we have not changed our strategy to increase our pass out's. ... As of now, we are not thinking of changing our strategy."
Shirish Patel: "So attrition, I would say that there is hardly any attrition rather I would say that there is a zero attrition among top 10% partners or our top 20% of our partners."
New Product & Regulatory Opportunities
- SIF product bullish but capacity-constrained: Management is very bullish on the SIF (Specialized Investment Fund) category, but out of 34,000-35,000 ARN holders, only 200-plus are certified for SIF, limiting current participation.
- SEBI draft strategically positive: The proposal to make expense ratios exclusive of GST removes an anomaly where GST-registered distributors earned less than unregistered ones. Management calls this strategically a huge benefit even though it is revenue-neutral.
- Nippon TER communication: Nippon has communicated it will revisit TER sharing every quarter and half-year; if there is significant yield pressure, it might change terms on the back book side. No other AMC has initiated discussions on back book repricing.
Sanjay Shah: "So even though it's neutral in revenue terms, it's strategically a huge benefit for us."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Monthly SIP flow | Reach ~₹1,200 crores | By March 2026 |
| Insurance GST clarity | Final picture on revenue impact and settlement arrangement communicated | End of current quarter (after December) |
| Non-financial products growth | Healthy YoY growth trend resumes as liquiloan base effect tapers | H2 FY26 |
| Commission provisioning | Lower provisioning in H2 vs last year as phasing is now more even | H2 FY26 |
| SEBI draft impact sharing | If impact transferred to distributors, Prudent will share pain with its distributors | Contingent on final regulation |
| Commission sharing ratio | Maintain current sharing ratio | Ongoing |
Key Metrics
| Metric | Q2 FY26 |
|---|---|
| Quarterly average AUM | ₹1,19,000 cr, up 17% YoY and 8% QoQ; excludes Indus AUM integrated in last week of September |
| Equity AUM | ₹1,17,650 cr, up 13.2% YoY and 3.3% QoQ; net sales of ₹3,600 cr and Indus AUM addition of ₹2,050 cr |
| Monthly SIP book | ₹1,085 cr as of Sep '25, added ~₹210 cr over last 12 months |
| SIP market share | 3.5%, up 10 bps from 3.4% in Sep '24 |
| Mutual fund revenue growth | 9% sequentially, vs 8% sequential AUM growth; benefit of additional 1 day (~₹3 cr) |
| Mutual fund revenue growth (half-yearly) | 18.4%, vs 19.8% half-yearly AUM growth; marginal difference due to back book repricing |
| Insurance revenue growth | 11.5% sequentially, driven by strong traction in fresh premiums |
| Retail health fresh premium growth | 33% YoY; book at ₹162.5 cr |
| Commission and fee expense growth | 10%, vs 8.9% revenue growth; incremental ₹2 cr trail commission provision in Q2 |
| Operational profit growth | 7.3% sequentially |
| Combined profitability drag (lower other income + additional trail provision) | ₹4.3 cr |
| Treasury corpus | ₹480 cr |
| New MFDs/ARN holders recruited (YTD) | ~3,100, vs ~4,800+ in full FY25 |
| Weighted average sharing (indirect channel) | 67%–68% |
| Mid and small-cap contribution to equity assets | ~23%–24% |